| Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ... Nature communications 10 (1), 1842, 2019 | 240 | 2019 |
| Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, JC Maggiore, ... Cell systems 12 (1), 41-55. e11, 2021 | 99 | 2021 |
| Development of a DNA-liposome complex for gene delivery applications M Rasoulianboroujeni, G Kupgan, F Moghadam, M Tahriri, A Boughdachi, ... Materials Science and Engineering: C 75, 191-197, 2017 | 74 | 2017 |
| Synthetic immunomodulation with a CRISPR super-repressor in vivo F Moghadam, R LeGraw, JJ Velazquez, NC Yeo, C Xu, J Park, A Chavez, ... Nature cell biology 22 (9), 1143-1154, 2020 | 42 | 2020 |
| Engineered CRISPR systems for next generation gene therapies M Pineda, F Moghadam, MR Ebrahimkhani, S Kiani ACS synthetic biology 6 (9), 1614-1626, 2017 | 41 | 2017 |
| Chuva de Sousa Lopes, SM; et al JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, JC Maggiore, ... Gene regulatory network analysis and engineering directs development and …, 2021 | 25 | 2021 |
| Chuva de Sousa Lopes SM et al (2021) Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, JC Maggiore, ... Cell Syst 12, 41-55, 0 | 15 | |
| Draft genome sequence and detailed analysis of Pantoea eucrina strain Russ and implication for opportunistic pathogenesis F Moghadam, MB Couger, B Russ, R Ramsey, RA Hanafy, C Budd, ... Genomics data 10, 63-68, 2016 | 11 | 2016 |
| Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat Commun 2019; 10 (1): 1842 SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ... | 6 | |
| Synthetic maturation of multilineage human liver organoids via genetically guided engineering JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, J Hislop, ... BioRxiv, 2020.05. 10.087445, 2020 | 5 | 2020 |
| Modulating human Cas9-specific host immune response R Ewaisha, S Kiani, SR Ferdosi, K Anderson, F Moghadam, S Krishna, ... US Patent 11,208,640, 2021 | 4 | 2021 |
| CRISPR-Based Synthetic Gene Circuits as Next Generation Gene Therapy of Inner Ear S Kiani, S Pradhan, F Moghadam, MR Ebrahimkhani US Patent App. 16/626,013, 2021 | 2 | 2021 |
| CRISPR logic circuits for safer and controllable gene therapies S Kiani, MR Ebrahimkhani, S Pradhan, F Moghadam US Patent 11,773,407, 2023 | 1 | 2023 |
| Modulating Human Cas9-Specific Host Immune Response R Ewaisha, S Kiani, SR Ferdosi, K Anderson, F Moghadam, S Krishna, ... US Patent App. 18/778,083, 2024 | | 2024 |
| Modulating human Cas9-specific host immune response R Ewaisha, S Kiani, SR Ferdosi, K Anderson, F Moghadam, S Krishna, ... US Patent 12,084,691, 2024 | | 2024 |
| Synthetic immunomodulation with a crispr super-repressor in vivo S Kiani, MR Ebrahimkhani, F Moghadam US Patent App. 18/535,658, 2024 | | 2024 |
| Synthetic immunomodulation with a CRISPR super-repressor in vivo S Kiani, MR Ebrahimkhani, F Moghadam US Patent 11,884,925, 2024 | | 2024 |
| Developing safe and controllable Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based therapies with design principles of synthetic biology F Moghadam Arizona State University, 2020 | | 2020 |
| Genetically guided engineering of human liver tissue from pluripotent stem cells M Ebrahimkhani, J Velzaquez, R Legraw, F Moghadam, J Kilbourne, ... 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The …, 2019 | | 2019 |
Samira KianiSchool of Biological and Health Systems Engineering-Arizona State UniversityVerified email at asu.edu
